SecBot SecBot
SECBOTREPLAY Home › Report › VRTX

VRTX · Director Sangeeta Bhatia filed a Form 144 notice of intent to sell 271…

VERTEX PHARMACEUTICALS INC / MA · 144 filed Nov 16, 2026 at 10:22 ET

At the news

NEUTRALIMPACT 1/10

144 filed Nov 16, 2026 at 10:22 ET

Director Sangeeta Bhatia filed a Form 144 notice of intent to sell 271 shares of Vertex Pharmaceuticals, valued at approximately $148,470. The shares were acquired via restricted stock vesting on May 1, 2025, as compensation. The sale is de minimis relative to the company's $137.6B market cap and the insider's total holdings, and is routine for director compensation.

  • Filer: Sangeeta Bhatia, Director of Vertex Pharmaceuticals
  • Shares to be sold: 271 shares of common stock
  • Approximate dollar value: $148,470.06
  • Shares acquired on May 1, 2025 via restricted stock vesting (compensation)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access